Thank you for being my sole source of Northern Exposure content on here! It makes me happy whenever I see it on my dash!
aww I love to hear it! This show is so special to me (I was watching it with my parents before I could even read and write :), so I'm always happy to see it getting appreciated <3
3 notes
·
View notes
Before more pathologic art shows up on my blog, just wanted to say I still do draw art of winx!
Alot of it is just in the WIP stage and I struggle to finish a piece esp after long stretches of not working on them 😭
My motivation (and skill) also only extends to simple busts atm so alot of the things I want to draw are out of my reach...but hopefully that changes
Either way, thanks for all the support on the art so far! More to come soon :D
3 notes
·
View notes
I'm happy to give you some feedback, I just wanted to ask if there was a specific reason you did not do any post processing. No judgment or anything, but the reason could help me give you better advice.
The easiest answer is... I don't know where to start. I have NX Studio, and know how to fix the obvious problems like a lopsided image or obviously over or under exposed. But one that looks... okay? I'm lost.
1 note
·
View note
I'm seeing information about the Novavax being formulated for the previous variant and the Moderna and Pfizer being for a more recent one. Is this true and if so, why are so many people trying to get the Novavax?
Hi, glad you asked! Here's a few posts on this:
Graphic (albeit from Novavax, no 3rd-party trials) showing broad neutralization:
Another, thread explaining the above. Particularly:
"Ultimately as the antigenic distance is very close for all major circulating variants, all vaccine options should be very good, and provide good protection against infection and severe disease (even when compared with infection-acquired/natural immunity)."
One more, from NPR:
https://www.npr.org/sections/shots-health-news/2024/08/22/nx-s1-5082372/updated-covid-vaccines-fda-approved
The Pfizer-BioNTech and Moderna ... now target the KP.2 variant ...
The Novavax vaccine, which is based on an older technology, targets an earlier strain of the virus called JN.1.
As many of us know by now, the virus continues evolving to better evade our immune defense, which means regularly updating the vaccines to keep up with the latest strain.
It turns out the KP.2 and JN.1 variants have already been overtaken by newer variants. Because those are also descendants of omicron, the hope is that the new vaccines are close enough matches that they can still boost immunity and protect people in the coming months – ideally reducing the chances of a big winter wave.
“The vaccine is not intended to be perfect. It’s not going to absolutely prevent COVID-19," Dr. Peter Marks from the FDA told NPR in an interview.
"But if we can prevent people from getting serious cases that end up in emergency rooms, hospitals or worse — dead — that’s what we’re trying to do with these vaccines.”
There's a couple of other points I do not have sources for right now; if anyone would like to reblog and add some or correct this, please do!:
I've read that in the past, for example, flu vaccine efficacy was not necessarily dampened when the vax targeted a "parent". They are in the same lineage, so efficacy should be good.
Analogy (albeit imperfect): using a net vs a spear.
Of course, without more data, we don't know. I would wager that people who choose Novavax nowadays may also be informed on #Layered Protection and prioritize physical barriers (N95 masking) as the first line of defense, with vaccine as secondary bonus, since any of them have a non-negligible % of breakthroughs at this point.
It was different in 2021 when they were first released and showed high efficacy; ~3% breakthrough, if that. Now, I would not in any case rely on Pfizer or Moderna alone, so there's not much of a reason to suffer their ill effects for days.
But bodies are all different. Some people tolerate them well. Some have no other choice. As always, get the one you can, that works for you!
47 notes
·
View notes